ahda, mustofa and Suhendra, Suhendra and Permadi, Adi Spirulina Platensis Microalgae as High Protein�Based Products for Diabetes Treatmen. [Artikel Dosen]
Text
Spirulina Platensis Microalgae as High Protein Based Products for Diabetes Treatment.pdf Download (1MB) |
Abstract
Spirulina (Arthrospira platensis) is a protein-rich source because it contains
approximately 60% protein. Therefore, it has positive impacts on human
health, including anti-diabetes. The potential of Spirulina platensis as an anti�diabetic agent has been investigated in-vitro and in-vivo. Its extract is cap�able of inhibiting amylase, α-glucosidase, and DPP IV enzymes in a range of
medium activities. Furthermore, spirulina at 250 mg/Kg body weight (BW) in
mice can reduce blood glucose levels with similar outcomes to the positive
controls (pioglitazone and glibenclamide). Protein groups (Phycocyanin),
isolated peptides, and flavonoid groups such as Pinocembrin, Acacetin, and
others have been predicted to be responsible for lowering glucose levels. In
the market, several commercial products have been sold. Many commercial
products have been sold in the market. However, these products are food
supplements because a clinical study has not yet been undertaken to confirm
their potency and safety. According to this analysis, there is a significant
chance to produce anti-diabetic medications from spirulina sources in the
future
Item Type: | Artikel Dosen |
---|---|
Subjects: | R Medicine > RS Pharmacy and materia medica R Medicine > RV Botanic, Thomsonian, and eclectic medicine |
Divisi / Prodi: | Faculty of Industrial Technology (Fakultas Teknologi Industri) > S2-Chemical Engineering(S2-Teknik Kimia) |
Depositing User: | Ph.D Adi Permadi |
Date Deposited: | 24 Aug 2023 23:45 |
Last Modified: | 24 Aug 2023 23:45 |
URI: | http://eprints.uad.ac.id/id/eprint/49347 |
Actions (login required)
View Item |